Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023

Lessons Learned from the DNA of Patients with Psychiatric Disorders – Daniel Weinberger, MD

Neurology and Psychiatry Interface – Martin Samuels, MD, DSc (hon)

The Interface of Medical and Psychiatric Disorders – Focus on Cancer and Heart Disease – Charles Nemeroff, MD, PhD

Tackling Unsolved Problems in the Pharmacological Treatment of Schizophrenia – Cognitive Impairment, Negative Symptoms, and Partial Treatment Response – Philip Harvey, PhD

Panel Discussion – Philip Harvey, PhD, Charles Nemeroff, MD, PhD, Martin Samuels, MD, DSc (hon), and Daniel Weinberger, MD

Pharmacological Treatment of Bipolar Disorder – Ross Baldessarini, MD, DSc (hon)

Anxiety – Treat the Symptom or Treat the Disorder When First Line Therapies Fail – Stephen M. Stahl, MD, PhD, DSc (hon)

Neurobiology and Treatment of Post-traumatic Stress Disorder – Charles Nemeroff, MD, PhD

Panel Discussion – Ross Baldessarini, MD, DSc (hon) and Charles Nemeroff, MD, PhD

Psychopharmacologic Treatment of Sleep Disorders – Sogol Javaheri, MD

Treatment Resistant Depression – Stephen M. Stahl, MD, PhD, DSc (hon)

Psychedelics and Potential Drugs of Abuse as Antidepressants – Alan F. Schatzberg, MD

Pharmacotherapy of Substance Use Disorders – Roger D. Weiss, MD

Panel Discussion – Barbara Coffey, MD, MS, Sogol Javaheri, MD, Alan F. Schatzberg, MD, Stephen M. Stahl, MD, PhD, DSc (hon), and Roger D. Weiss, MD

Child and Adolescent Psychopharmacology – Current Treatment for Best Practices – Barbara J. Coffey, MD, MS

Psychopharmacology Across the Reproductive Lifespan – From Menarche to Menopause – Ariadna Forray, MD

Geriatric Psychopharmacology – Elizabeth Crocco, MD

Panel Discussion – Barbara J. Coffey, MD, MS, Elizabeth Crocco, MD, and Ariadna Forray, MD